The U.S. Food and Drug Administration on Friday approved an alopecia treatment for kids, marking a historic first. The drug, ritlecitinib, is a once-daily pill for kids ages 12 and older with severe ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. The Food and Drug Administration approved the first-ever systemic ...

Please provide your email address to receive an email when new articles are posted on . Methotrexate and low-dose prednisone combination allowed complete hair regrowth in up to 31% of patients. Only ...

Alopecia universalis (AU) is a rare autoimmune condition that involves complete loss of hair on your face, scalp, and body. The earlier you seek treatment, the better your chances of maintaining your ...

A bibliometric analysis reveals a significant increase in research on alopecia areata treatment over the past 2 decades, with a focus on identifying effective therapies and understanding underlying ...

Patients with alopecia areata (AA) have a higher risk of cardiovascular disease, especially those with alopecia totalis or universalis. The study analyzed data from 238,270 patients across three ...

The U.S. Food and Drug Administration on Monday announced it approved a new drug to treat severe alopecia areata, an autoimmune condition that often leads to patchy hair loss on both the head and ...

TAMPA (BLOOM) – Alopecia Universalis (AU) stands as one of the most severe forms of hair loss, yet it remains shrouded in mystery. This condition doesn’t just result in the loss of scalp hair but ...